These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34. The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome. Lee C; Greene SL; Wong A Clin Toxicol (Phila); 2019 Sep; 57(9):773-777. PubMed ID: 30729854 [No Abstract] [Full Text] [Related]
35. Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series. Dezieck L; Hafez Z; Conicella A; Blohm E; O'Connor MJ; Schwarz ES; Mullins ME Clin Toxicol (Phila); 2017 Sep; 55(8):908-913. PubMed ID: 28494183 [TBL] [Abstract][Full Text] [Related]
36. Propranolol Treatment of Cannabinoid Hyperemesis Syndrome: A Case Report. Richards JR; Dutczak O J Clin Psychopharmacol; 2017 Aug; 37(4):482-484. PubMed ID: 28604421 [No Abstract] [Full Text] [Related]
37. Cannabinoid hyperemesis syndrome: Clinical trajectories and patterns of use three months following a visit to the emergency department. Wightman RS; Metrik J; Lin TR; Collins AB; Beaudoin FL Acad Emerg Med; 2024 May; 31(5):463-470. PubMed ID: 37387520 [TBL] [Abstract][Full Text] [Related]
39. Haloperidol Use in the Emergency Department for Gastrointestinal Symptoms: Nausea, Vomiting, and Abdominal Pain. Shahsavari D; Reznick-Lipina K; Malik Z; Weiner M; Jehangir A; Repanshek ZD; Parkman HP Clin Transl Gastroenterol; 2021 Jun; 12(6):e00362. PubMed ID: 34060494 [TBL] [Abstract][Full Text] [Related]
40. Cannabinoid hyperemesis syndrome in two French emergency departments: a prospective cohort. Weiss J; Torrents R; Verhamme B; Roch A; Lazerges P; Jego M; Michelet P; Simon N Fundam Clin Pharmacol; 2021 Feb; 35(1):186-191. PubMed ID: 32564375 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]